Riverbridge Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $95.1M | Sell |
|
|||||
|
2025
Q2 | $83.9M | Sell |
|
|||||
|
2025
Q1 | $91.4M | Sell |
|
|||||
|
2024
Q4 | $143M | Sell |
|
|||||
|
2024
Q3 | $137M | Sell |
|
|||||
|
2024
Q2 | $160M | Sell |
|
|||||
|
2024
Q1 | $199M | Sell |
|
|||||
|
2023
Q4 | $182M | Sell |
|
|||||
|
2023
Q3 | $197M | Sell |
|
|||||
|
2023
Q2 | $216M | Buy |
|
|||||
|
2023
Q1 | $187M | Buy |
|
|||||
|
2022
Q4 | $119M | Sell |
|
|||||
|
2022
Q3 | $130M | Buy |
|
|||||
|
2022
Q2 | $140M | Sell |
|
|||||
|
2022
Q1 | $229M | Sell |
|
|||||
|
2021
Q4 | $290M | Buy |
|
|||||
|
2021
Q3 | $262M | Buy |
|
|||||
|
2021
Q2 | $221M | Buy |
|
|||||
|
2021
Q1 | $167M | Buy |
|
|||||
|
2020
Q4 | $160M | Sell |
|
|||||
|
2020
Q3 | $162M | Sell |
|
|||||
|
2020
Q2 | $138M | Buy |
|
|||||
|
2020
Q1 | $88.9M | Sell |
|
|||||
|
2019
Q4 | $88.5M | Sell |
|
|||||
|
2019
Q3 | $84M | Buy |
|
|||||
|
2019
Q2 | $72.8M | Sell |
|
|||||
|
2019
Q1 | $66.9M | Sell |
|
|||||
|
2018
Q4 | $60.7M | Sell |
|
|||||
|
2018
Q3 | $80M | Buy |
|
|||||
|
2018
Q2 | $46.7M | Sell |
|
|||||
|
2018
Q1 | $43.2M | Sell |
|
|||||
|
2017
Q4 | $48.5M | Sell |
|
|||||
|
2017
Q3 | $50.2M | Buy |
|
|||||
|
2017
Q2 | $48.3M | Buy |
|